Megestrol acetate for treatment of anorexia-cachexia syndrome-Reference-Cited by-同舟云学术

Megestrol acetate for treatment of anorexia-cachexia syndrome

Published:2013-03-28 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ruiz Garcia Vicente¹,López-Briz Eduardo²,Carbonell Sanchis Rafael³,Gonzalvez Perales Jose Luis⁴,Bort-Martí Sylvia⁵

Affiliation:

1. La Fe University Hospital; Hospital at Home Unit & CASPe Spain; Av Fernando Abril Martorell nº 106 Valencia Spain 46026

2. La Fe University Hospital; Department of Pharmacy & CASP Spain; Avda Fernando Abril Martorell 106 Valencia Valencia Spain 46026

3. Sagunt Hospital; ENT Department; Ramón y Cajal 46 Sagunt Valencia Spain 46520

4. National Health Service; Plaza de la Ribera s/n Algemesi Valencia Spain 46680

5. HIPRA; Avda de la Selva 135 Amer, Girona Spain 17170

Publisher

Wiley

Subject

Pharmacology (medical)

Reference191 articles.

1. Randomised prospective medium term comparison of megestrol acetate, nandrolone decanoate and dietary therapy alone for HIV associated weight loss [abstract];Batterham;Australasian Society for HIV Medicine,1997

2. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss;Batterham;International Journal of Andrology,2001

3. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial;Beller;Annals of Oncology,1997

4. Casado Herráez A Phase II randomized study of two dose levels of megestrol acetate versus placebo for the treatment of anorexia and cachexia in patients with locoregional advanced or metastatic cancer Available from http://eprints.ucm.es/8119/1/T30450.pdf

5. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial;Conno;European Journal of Cancer,1998

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients;Cancers;2023-11-26

2. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management;Biochemical Pharmacology;2023-10

3. Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status;Cancers;2023-09-09

4. Update on the treatment of cancer cachexia;Drug Discovery Today;2023-09

5. The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors;Cancer Management and Research;2023-09